The Company remains focused on securing additional financing to execute its strategic plan in rare diseases Exclusive discussions with a leading...
Regulatory News: Poxel (Paris:POXEL) : Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du...
TWYMEEG sales in Japan for the last quarter (July-September) grew by 28% over the prior quarter. Current trajectory, if maintained, would lead...
Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société biopharmaceutique au stade clinique développant des traitements innovants...
Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516) (Paris:POXEL), société biopharmaceutique au stade clinique développant des...
TWYMEEG sales in Japan for the last quarter (April-June) grew 23% over the prior quarter, in line with Sumitomo Pharma’s FY 2023 forecast1...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.